SPONSOR
Children's Hospital Medical Center, Cincinnati
Total Trials
14
Recruiting
14
Phases
Phase 4, Phase 2, Phase 1, Phase 2
Conditions studied: Congenital Dyserythropoietic Anemia (CDA)Pectus ExcavatumMajor Depressive Disorder (MDD)Suicidal IdeationHospitalization in ChildrenHematologic MalignancyLeukemiaLymphomaAcute Lymphocytic LeukemiaALL
Children's Hospital Medical Center, Cincinnati is a clinical research sponsor with 14 registered studies on ClinicalTrials.gov, of which 14 are actively recruiting participants. Research covers conditions including Congenital Dyserythropoietic Anemia (CDA), Pectus Excavatum, Major Depressive Disorder (MDD), Suicidal Ideation.
The trial portfolio spans Phase 4, Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Children's Hospital Medical Center, Cincinnati
How many clinical trials has Children's Hospital Medical Center, Cincinnati sponsored?
ClinicalMetric currently tracks 14 clinical trials sponsored by Children's Hospital Medical Center, Cincinnati, of which 14 are actively recruiting participants. These trials cover conditions including Congenital Dyserythropoietic Anemia (CDA), Pectus Excavatum, Major Depressive Disorder (MDD). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Children's Hospital Medical Center, Cincinnati research focus on?
Children's Hospital Medical Center, Cincinnati clinical trials span Congenital Dyserythropoietic Anemia (CDA), Pectus Excavatum, Major Depressive Disorder (MDD), Suicidal Ideation, Hospitalization in Children, and additional conditions. The research pipeline includes Phase 4, Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Children's Hospital Medical Center, Cincinnati clinical trial?
To participate in a Children's Hospital Medical Center, Cincinnati trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Children's Hospital Medical Center, Cincinnati trials with current recruitment status updated daily.
Clinical Trials by Children's Hospital Medical Center, Cincinnati
NCT02964494
Recruiting
The Congenital Dyserythropoietic Anemia Registry (CDAR)
Congenital Dyserythropoietic Anemia (CDA)
NCT06682208
Recruiting
ES Catheter vs Cryoablation After Pectus Surgery
Pectus Excavatum
NCT07217444
Recruiting
Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation
Major Depressive Disorder (MDD)
NCT06131801
Recruiting
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Hematologic Malignancy
NCT06896942
Recruiting
Autism Doula Program Evaluation
Health Equity
NCT02461615
Recruiting
A National Registry For Pulmonary Alveolar Proteinosis
Pulmonary Alveolar Proteinosis
NCT04219280 Phase 4
Recruiting
Evaluating Treatment of ADHD in Children with Down Syndrome
Down Syndrome
NCT06175104
Recruiting
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
Heart Defects, Congenital
NCT05485155 Phase 2
Recruiting
Zemaira Eosinophilic Esophagitis Pilot Study
Eosinophilic Esophagitis
NCT06713330
Recruiting
Comparing Stainless Steel Crowns With Prefabricated Resin Crowns in Primary Molar Teeth
Dental Caries
NCT06705907
Recruiting
Improving Academic and Social Functioning in Middle-Schoolers With Autism
Autism
NCT02532452 Phase 2
Recruiting
Third Party Viral Specific T-cells (VSTs)
Viral Infection
NCT04089254
Recruiting
Suicide Treatment Alternatives for Teens
Suicidal Ideation
NCT05580601 Phase 1, Phase 2
Recruiting
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology